HGE Health's Telemedicine Technology Enables Nation's Leading Lung Transplant Hospital to Offer High Quality Care to Geographically Dispersed Lung Transplant Patients

MarketsInsider.png
 

PHILADELPHIA, Jan. 31, 2018 /PRNewswire-PRWeb/ -- HGE Health, a healthcare technology company that works worldwide with pulmonary surgeons and physicians, is expanding the roll out of its digital telemedicine platform and mobile app that enables lung transplant surgeons caring for patients pre- and post-lung transplant to have more medically advantageous communications with those patients, radically improving the centers' ability to scale its high quality care to a rapidly growing patient population.

The expansion comes as Temple Lung Center at Temple UniversityHospital -- the most active lung disease and lung transplant center in the United States – has seen dramatic increases in both the number of lung transplants performed annually and the distance patients are traveling to be treated at Temple. The software-as-a-service (SaaS) digital planform and app, called HGE Care Advanced, has been successfully deployed in both the U.S. and Europe where it has proven exceptionally valuable in keeping pulmonary patients stable pre-surgery and in mitigating post-surgery pulmonary complications.

"We've gone from 40 to over 130 lung transplants annually in a very short period of time," said Francis C. Cordova, MD, Professor, Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University and Medical Director, Lung Transplantation Program, Temple University Hospital. "Our goal is to continue to increase the number of transplants we perform each year and to expand our geographic footprint, while continuing to provide the high-quality care that is synonymous with the Temple Lung Center pre- and post-surgery. HGE Care Advanced will improve our ability to expand care for our growing list of patients nationwide."

"We've been thrilled with the results of our HGE Care Advanced application in both immediate surgical and more long-term management of patients' pulmonary symptoms," said Michael J. Markus, PhD, CEO of HGE Health. "The platform allows physicians to remotely manage a transplant patient from anywhere in the nation before and after travel for their lung transplant. Thanks to a daily digital interaction with their healthcare team, the mobile app provides patients peace of mind that, pre-surgery, they stand a better chance of keeping their health stable and remaining on a lung transplant waiting list. More importantly, post-surgery, patients benefit from daily connectivity with their transplant care team, regardless of where they are, ensuring the patient and their new lungs have the best chance to avoid post-procedure complications and readmission."

"We're excited to see HGE Health's technological innovation continue to play a key role in the health and wellbeing of pulmonary patients," said Larry R. Kaiser, MD, FACS, president and CEO, Temple University Health System. "Along with our talented transplant team, HGE Health is one of the reasons the Temple Lung Center has become the busiest and best pulmonary program in the nation. They have made it easier for patients and physicians from not only across the U.S. but around the world to take advantage of our life-saving expertise."

About HGE Health
Headquartered in Philadelphia, HGE Health harnesses it's deep experience in chronic disease management and digital health in pulmonary disease, telemedicine and mobile health to develop a clinical services platform that delivers better care faster at a much lower cost for patients, physicians and payors. Built on clinical protocols developed and supported by 16 years of research, the company's technology has compiled the longest running and world's largest longitudinal data set of COPD symptoms, interventions and clinical management to help physicians provide care for a geographically and socio-economically diverse COPD patient population.